Results 101 to 110 of about 9,896 (218)

Site-Specific PEGylation of Recombinant Immunotoxin DAB389IL-2: Structural and Functional Assessment

open access: yesResearch in Molecular Medicine, 2019
Background: DAB389IL-2 is considered a fusion immunotoxin and it is used for the CTCL therapy. DAB389IL-2 includes of two distinct portions; the catalytic domain of diphtheria toxin and IL-2. DAB389IL-2 duo to the presence of a free cysteine residue (Cys
Nasrin Zarkar   +5 more
doaj  

No evidence of family history as a risk factor for herpes zoster in patients with post-herpetic neuralgia [PDF]

open access: yes, 2010
Little is known about reactivation of latent varicella zoster virus as herpes zoster in individuals with no underlying immunosuppression. Risk factors include age, sex, ethnicity, exogenous boosting of immunity from varicella contacts, underlying cell ...
Boccia, Mt   +5 more
core   +1 more source

Eye-specific retinogeniculate segregation proceeds normally following disruption of patterned spontaneous retinal activity [PDF]

open access: yes, 2014
Background: Spontaneous retinal activity (SRA) is important during eye-specific segregation within the dorsal lateral geniculate nucleus (dLGN), but the feature(s) of activity critical for retinogeniculate refinement are controversial.
Chapman, Barbara   +5 more
core   +3 more sources

Species-Dependent Functionality of the Human Cytolytic Fusion Proteins Granzyme B-H22(scFv) and H22(scFv)-Angiogenin in Macrophages

open access: yesAntibodies, 2013
Human cytolytic fusion proteins (hCFPs) are comprised of a specific cell-surface-binding moiety and an effector molecule of human origin. In contrast to common immunotoxins, including bacterial or plant toxins, they are considered not to be immunogenic ...
Theo Thepen   +7 more
doaj   +1 more source

Review of Varicella zoster virus : from epidemiology to prevention [PDF]

open access: yes, 2008
The Varicella zoster virus is a human pathogen which causes Varicella after primary infection and herpes zoster after secondary reactivation. Both disease manifestations can occur at any age; however, Varicella is seen more commonly in children whilst ...
Pace, David
core  

Dysregulated Expression of Glycolipids in Tumor Cells: From Negative Modulator of Anti-Tumor Immunity to Promising Targets for Developing Therapeutic Agents

open access: yesFrontiers in Oncology, 2016
Glycolipids are complex molecules consisting of a ceramide lipid moiety linked to a glycan chain of variable length and structure. Among these are found the gangliosides, which are sialylated glycolipids ubiquitously distributed on the outer layer of ...
Jose Luis Daniotti   +2 more
doaj   +1 more source

The monoclonal antibody nBT062 conjugated to maytansinoids has potent and selective cytotoxicity against CD138 positive multiple myeloma cells _in vitro_ and _in vivo_ [PDF]

open access: yes, 2008
CD138 (Syndecan1) is highly expressed on multiple myeloma (MM) cells. In this study, we examined the anti-MM effect of murine/human chimeric CD138-specific monoclonal antibody (mAb) nBT062 conjugated with highly cytotoxic maytansinoid derivatives _in ...
Benjamin Dä   +20 more
core   +1 more source

Advances in Targeted Toxin Therapy for Malignant Gliomas: A Narrative Review

open access: yesToxins
Malignant gliomas remain highly treatment-resistant brain tumors despite surgery and adjuvant therapies. Targeted toxin therapies represent a unique strategy that exploits receptor-mediated cellular internalization to deliver cytotoxic components that ...
Hanish Polavarapu, Walter A. Hall
doaj   +1 more source

Hairy cell leukemia, an uncommon B-cell lymphoid neoplasia [PDF]

open access: yes, 2016
Hairy cell leukemia (HCL) is an uncommon B-cell lymphoid neoplasia, representing 2---3% of all leukemias. It is more common in men, with a median age at diagnosis of 52 years.
Garza Ledezma, María Alejandra   +3 more
core  

Codominance and toxins: A path to drugs of nearly unlimited selectivity [PDF]

open access: yes, 1995
The effectiveness of drugs is often limited by their insufficient selectivity. I propose designs of therapeutic agents that address this problem. The key feature of these reagents, termed comtoxins (codominance-mediated toxins), is their ability to ...
Varshavsky, Alexander
core  

Home - About - Disclaimer - Privacy